Drug General Information
Drug ID
D09TDY
Former ID
DNC009884
Drug Name
EPIMER A
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530247]
Formula
C27H23N5O3
Canonical SMILES
C1C2CN(C3=CC=CC(=C23)NC1=O)CC(=O)NC4=CC5=C(CC6(C5)C7=C(<br />NC6=O)N=CC=C7)C=C4
InChI
1S/C27H23N5O3/c33-22-10-17-13-32(21-5-1-4-20(30-22)24(17)21)14-23(34)29-18-7-6-15-11-27(12-16(15)9-18)19-3-2-8-28-25(19)31-26(27)35/h1-9,17H,10-14H2,(H,29,34)(H,30,33)(H,28,31,35)/t17?,27-/m0/s1
InChIKey
YMMTXWRRJUTBEI-LYTHVRBOSA-N
PubChem Compound ID
Target and Pathway
Target(s) Calcitoningene-related peptide type 1 receptor Target Info Inhibitor [530247]
KEGG Pathway Neuroactive ligand-receptor interaction
Vascular smooth muscle contraction
Reactome G alpha (s) signalling events
Calcitonin-like ligand receptors
WikiPathways GPCRs, Class B Secretin-like
Endothelin Pathways
GPCR ligand binding
GPCR downstream signaling
References
Ref 530247Bioorg Med Chem Lett. 2009 Aug 15;19(16):4740-2. Epub 2009 Jun 17.The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists.
Ref 530247Bioorg Med Chem Lett. 2009 Aug 15;19(16):4740-2. Epub 2009 Jun 17.The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists.